AIM

AIM ImmunoTech
AIM

Overview Fund Trends Analyst Outlook Journalist POV

13 hedge funds and large institutions have $1.53M invested in AIM ImmunoTech in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$462K
2
+$6.5K

Top Sellers

1
-$115K
2
-$31.5K
3
-$22K
4
BlackRock
BlackRock
New York
-$15.3K
5
PAM
Panagora Asset Management
Massachusetts
-$14K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$472K
2
$462K
3
$230K
4
$227K
5
$37K
6
$36K
7
$20K
8
$16K
9
$13K
10
$8K
11
$6K
12
$5K
13
$1K
14
$1K
15
–
16
–